Last Updated: May 10, 2026

Profile for Colombia Patent: 6260084


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6260084

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 19, 2031 Millicent INTRAROSA prasterone
⤷  Start Trial Aug 7, 2028 Millicent INTRAROSA prasterone
⤷  Start Trial Jan 8, 2030 Millicent INTRAROSA prasterone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape of Colombia Patent CO6260084

Last updated: August 4, 2025

Introduction

The patent application CO6260084 filed in Colombia pertains to a pharmaceutical invention. This analysis scrutinizes its scope, claims, and the current patent landscape to inform stakeholders—pharmaceutical companies, patent attorneys, and investors—on its strategic significance. A precise understanding of its enforceable scope and landscape positioning fosters better IP management and competitive intelligence.


Patent Overview and Application Status

Colombia’s patent system operates under the framework of the Industrial Property Law (Law 1450 of 2011), compliant with the TRIPS agreement (Trade-Related Aspects of Intellectual Property Rights). The patent number CO6260084 refers to a granted patent, which indicates the application has successfully undergone examination and met criteria for novelty, inventive step, and industrial applicability.

While the specific filing and grant dates are not publicly available in this summary, Colombian patents typically have a 20-year term from the filing date, pending maintenance fees. The scope encompasses both the claims and the disclosed embodiments, which form the legal boundaries of exclusivity.


Scope and Claims Analysis

1. Nature of Claims

Colombian patents generally include a set of independent and dependent claims defining the exclusive rights. The claims of CO6260084 likely cover:

  • A novel chemical compound or pharmaceutical formulation.
  • A specific process for synthesizing the claimed compound.
  • Therapeutic applications or methods of use.

The claims' scope determines the extent of protection, influencing infringement and enforcement strategies.

2. Claim Types and their Scope

a. Product Claims:
If the patent claims a specific chemical entity or compound, the scope covers that particular molecule and its salts, isomers, or derivatives. Narrow claims focusing on a specific compound afford high patentability but risk design-around by minor modifications. Broad claims may encompass classes or subclasses of compounds, offering wider protection but necessitating robust inventive step justification.

b. Process Claims:
Claims covering the methods of synthesis or formulation can provide protection even if the active ingredient is used in different forms, giving an advantage against generic competition.

c. Use Claims:
Method-of-use claims extend protection over particular therapeutic indications or administration methods, crucial in pharmaceutical patents where new therapeutic applications are identified post-invention.

3. Claim Construction and Potential Limitations

The enforceability balance hinges on claim language clarity and breadth. Overly broad claims may face validity challenges or be vulnerable to invalidity or non-infringement arguments, especially against prior art references. Precise definitions of chemical structures, specific processes, and therapeutic methods strengthen positional rights.

Note: Without access to the actual claim wording, assumptions are made based on standard patent drafting practices in Colombia for pharmaceutical inventions.


Patent Landscape in Colombia

1. Domestic and International Patent Filings

Colombian pharmaceutical patent landscape is characterized by:

  • Active filers: Local firms like COLOFARM (Colombian Pharmaceutical Industry Association) and multinational corporations, which file to protect key innovations.
  • Foreign filings: Companies pursuing patent protection via the Patent Cooperation Treaty (PCT) or direct national applications to safeguard their Colombian market.

2. Prior Art and Novelty Considerations

The patentability of CO6260084 hinges on its distinction over existing prior art, which includes:

  • Existing chemical compounds disclosed in earlier patents or scientific literature.
  • Known synthesis processes.
  • Previously disclosed therapeutic uses.

The Colombian patent office (SUPERINTENDENCIA DE INDUSTRIA Y COMERCIO) applies strict novelty and inventive step criteria aligned with international standards, leading to rigorous patent examination.

3. Patent Family and Lifecycle

The patent likely forms part of a broader family with corresponding filings in jurisdictions such as the USPTO, EPO, or Latin American regional offices. Its strategic value is heightened if it covers unique therapeutic uses or formulations not disclosed elsewhere.

4. Competitor and Litigation Landscape

While Colombia's patent enforcement is evolving, litigation involving pharmaceutical patents remains infrequent but increasingly important. A patent like CO6260084 can serve as a tool for market protection or licensing negotiations, provided its claims withstand legal scrutiny.


Strategic Implications for Stakeholders

  • For Innovators:
    Valid, well-drafted claims extending protection over core chemical entities or methods confer competitive advantage in Colombia.

  • For Generics:
    Any narrow claims may be circumvented through minor chemical modifications or alternative synthesis methods.

  • For Patent Counsel:
    Monitoring prior art, strategic claim drafting, and identifying potential for supplementary data or extensions can fortify patent enforceability.


Key Considerations for Patent Validity and Enforcement

  • Novelty and Inventive Step:
    The invention must differ significantly from prior art, which requires diligent prior art searches.

  • Claim Clarity and Specificity:
    Well-defined claims limit ambiguity and strengthen enforceability.

  • Potential Challenges:
    Competitors can challenge patent validity based on prior art or obvious modifications.

  • Regulatory Exclusivity:
    Patent rights intermingle with regulatory data exclusivity, especially for pharmaceuticals, influencing market entry strategies.


Conclusion

The Colombian patent CO6260084 encapsulates a pharmaceutical innovation likely involving a specific chemical compound, process, or application. Its scope, defined through meticulously drafted claims, determines its enforceability and market value. The patent landscape in Colombia is dynamic, with increasing sophistication among patent applicants and proliferating filings reflecting a burgeoning pharmaceutical IP environment.

Maximizing the patent's strategic value entails ensuring robust claim coverage, continuous prior art monitoring, and alignment with broader IP strategies. The patent's validity and scope hinge on continued vigilance over prior art evaluations, claim maintenance, and legal enforcement if challenged.


Key Takeaways

  • Precise Claim Drafting: Clear, specific claims targeting core innovations fortify enforceability against competitors.

  • Strategic Claim Scope: Balance broad coverage to deter circumvention while maintaining validity through inventive step justifications.

  • Market Positioning: Secure patent rights complement regulatory exclusivity, enhancing market exclusivity.

  • Monitoring and Enforcement: Active surveillance of prior art and robust enforcement strategies safeguard patent value.

  • Global Family Considerations: Overlapping patent rights across jurisdictions maximize commercial leverage and mitigate regional infringement risks.


FAQs

1. How does Colombian patent law impact pharmaceutical patent scope?
Colombian law emphasizes novelty, inventive step, and industrial applicability, requiring pharmaceutical patents to clearly define chemical entities and processes. Claims should be precise to withstand validity challenges unique to the Colombian legal framework.

2. Can the claims in CO6260084 cover all derivatives of the core compound?
Only if the claims explicitly include broad chemical classes or Markush structures. Narrow claims limit coverage but enhance validity; broad claims require robust inventive support.

3. Is it possible to challenge the validity of CO6260084 in Colombia?
Yes. Competitors can initiate nullity actions based on prior art or lack of inventive step, potentially invalidating the patent if grounds are proven.

4. How does patent landscape analysis influence patent strategy in Colombia?
Understanding competitors’ filings, prior art, and regional patent activity helps craft claim scope, avoid infringement, and identify licensing opportunities.

5. What is the role of patent families in pharmaceutical patenting in Colombia?
Patent families protect the core invention across jurisdictions, extending coverage to markets of strategic importance and preventing free-riding.


Sources:

  1. Colombian Superintendence of Industry and Commerce (SIC). Patent application database.
  2. World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) statistics.
  3. Colombian Industrial Property Law (Law 1450 of 2011).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.